-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
iNature
Pancreatic cancer (PC) is the deadliest solid tumor worldwide
At present, surgical resection is still the main method for the treatment of pancreatic cancer, but nearly 70% to 80% of PC patients are diagnosed with advanced or locally advanced stage, and the possibility of radical tumor resection is only 8% to 12%
On August 9, 2022, the team of Zhou Yanbing from Qingdao University published a research paper online entitled "TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer" in Molecular Cancer (IF=41) magazine.
—END—The content is [iNature]